Company intelligence / Profile preview

Atuka

Toronto, Ontario, Canadatranslate.google.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Atuka has supported the preclinical evaluation of over 300 potential treatments for Parkinson’s and related conditions. More than 30 client programs have progressed to clinical trials based on data generated by Atuka. The company specializes in translational animal models—especially non-human primate models—for efficacy and target engagement studies. No proprietary clinical results as a service provider.

Therapeutic areas: Neurology
Modalities: Small moleculeMonoclonal antibodyGene therapyBiologic
Industry: Contract Research Organization

Partnerships

Michael J. Fox FoundationWeston Family FoundationUS Department of DefenceThomas Jefferson UniversityWorks with >90 organizations in pharma/biotech sector as clients.

Beyond the preview

Go deeper on Atuka.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atuka.

Explore the full profile